While Africa has been vital to development of HIV medication, Trump’s funding cuts to UN threatens vaccine research
Significant advances have included clinical trials for lenacapavir, the world’s only twice-a-year shot to prevent HIV, recently approved for use by the US Food and Drug Administration. One study to show its efficacy involved young South Africans.
UN: HIV catastrophe looms in poor countries unless hole left after US funding pause is plugged
The $4 billion that the United States pledged for the global HIV response for 2025 disappeared virtually overnight in January when US President Donald Trump ordered that all foreign aid be suspended and later moved to shutter the US AID agency.
Despite free prevention South Africa still records one of highest HIV infection rates in the world
The data in Gauteng shows that many of the women who gave birth this year to children with HIV did so in government-run health clinics where the free HIV testing and treatment is available.
